The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Johnson and Johnson announced that its Scios unit will spend over $100 million to test the safety and effectiveness of its heart failure drug, Natrecor. The new study will involve 7,000 people and will test safety issues that arose last year when other studies showed that the drug could lead to an increased risk of kidney problems and a higher risk of mortality within the first month of treatment, when compared with other medicines.

Comments are closed.

Of Interest